253 related articles for article (PubMed ID: 30004918)
1. IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody.
Lonze BE; Tatapudi VS; Weldon EP; Min ES; Ali NM; Deterville CL; Gelb BE; Benstein JA; Dagher NN; Wu M; Montgomery RA
Ann Surg; 2018 Sep; 268(3):488-496. PubMed ID: 30004918
[TBL] [Abstract][Full Text] [Related]
2. Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.
Lorant T; Bengtsson M; Eich T; Eriksson BM; Winstedt L; Järnum S; Stenberg Y; Robertson AK; Mosén K; Björck L; Bäckman L; Larsson E; Wood K; Tufveson G; Kjellman C
Am J Transplant; 2018 Nov; 18(11):2752-2762. PubMed ID: 29561066
[TBL] [Abstract][Full Text] [Related]
3. Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes).
Jordan SC; Legendre C; Desai NM; Lorant T; Bengtsson M; Lonze BE; Vo AA; Runström A; Laxmyr L; Sjöholm K; Schiött Å; Sonesson E; Wood K; Winstedt L; Kjellman C; Montgomery RA
Transplantation; 2021 Aug; 105(8):1808-1817. PubMed ID: 33093408
[TBL] [Abstract][Full Text] [Related]
4. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
Yuan XP; Wang CX; Gao W; Fu Q; He XS
Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
[TBL] [Abstract][Full Text] [Related]
5. Imlifidase therapy: exploring its clinical uses.
Rostaing L; Noble J; Malvezzi P; Jouve T
Expert Opin Pharmacother; 2023 Feb; 24(2):259-265. PubMed ID: 36404277
[TBL] [Abstract][Full Text] [Related]
6. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
[TBL] [Abstract][Full Text] [Related]
7. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
[TBL] [Abstract][Full Text] [Related]
8. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
Jordan SC; Lorant T; Choi J; Kjellman C; Winstedt L; Bengtsson M; Zhang X; Eich T; Toyoda M; Eriksson BM; Ge S; Peng A; Järnum S; Wood KJ; Lundgren T; Wennberg L; Bäckman L; Larsson E; Villicana R; Kahwaji J; Louie S; Kang A; Haas M; Nast C; Vo A; Tufveson G
N Engl J Med; 2017 Aug; 377(5):442-453. PubMed ID: 28767349
[TBL] [Abstract][Full Text] [Related]
9. Highly Sensitized Patients: Miami Transplant Institute Experience.
Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
11. Effects of Two Preemptive Post-transplant Desensitization Regimens Upon Renal Allograft Survival and DSA Elaboration.
Kimball PM; McDougan FA; King A
Clin Transpl; 2014; ():197-203. PubMed ID: 26281145
[TBL] [Abstract][Full Text] [Related]
12. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience.
Magee CC; Felgueiras J; Tinckam K; Malek S; Mah H; Tullius S
Transplantation; 2008 Jul; 86(1):96-103. PubMed ID: 18622284
[TBL] [Abstract][Full Text] [Related]
13. The impact of IdeS (imlifidase) on allo-specific, xeno-reactive, and protective antibodies in a sensitized rhesus macaque model.
DeLaura I; Zikos J; Anwar IJ; Yoon J; Ladowski J; Jackson A; Van Rompay K; Magnani D; Knechtle SJ; Kwun J
Xenotransplantation; 2024; 31(1):e12833. PubMed ID: 37864433
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates.
Rostaing L; Congy N; Aarnink A; Maggioni S; Allal A; Sallusto F; Game X; Kamar N
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():201-6. PubMed ID: 25894155
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
16. First use of imlifidase desensitization in a highly sensitized lung transplant candidate: a case report.
Roux A; Bunel V; Belousova N; Messika J; Tanaka S; Salpin M; Roussel A; Beaumont-Azuar L; Picard C; Brugiere O; Devaquet J; Sage E; Le Guen M; Taupin JL; Devriese M; Glorion M; Parquin F
Am J Transplant; 2023 Feb; 23(2):294-297. PubMed ID: 36695676
[TBL] [Abstract][Full Text] [Related]
17. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
[TBL] [Abstract][Full Text] [Related]
18. Management of sensitized pediatric patients prior to renal transplantation.
Pirojsakul K; Desai D; Lacelle C; Seikaly MG
Pediatr Nephrol; 2016 Oct; 31(10):1691-8. PubMed ID: 26801944
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A
Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib in ABO-incompatible kidney transplant desensitization: a case report.
Wong NL; O'Connell P; Chapman JR; Nankivell B; Kable K; Webster AC; Wong G
Nephrology (Carlton); 2015 Mar; 20 Suppl 1():22-4. PubMed ID: 25807854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
